Ahmed Mohamed falsely accused of making bomb gets a hero’s welcome at White House

Bengaluru, Jul 21: Students who are Covid-19 positive but are asymptomatic will be allowed to write the Common Entrance Test (CET) scheduled on July 30 and 31 for entrance into professional courses in Karnataka.

According to the Standard Operating Procedure (SOP) issued by the Department of Health and Family Welfare for CET, space should be allotted for students who have tested positive. Such students will have to be transported to and from the exam centre in an ambulance.

According to the SOP issued yesterday, candidates with COVID-19 “shall provide a risk consent certificate for taking up the exam.” The SOP also says “they shall inform about their status to the authorities concerned in advance to make the necessary arrangements.”

Mangaluru, Apr 18: Sauharda Forum in Moodbidri has placed a food-counter stand near Krishnakatte in Moodbidri here to feed the hungry during the lockdown.

Due to strict implementation of lockdown to prevent the spread of COVID-19, shops and hotels have remained closed since last one month posing a huge difficulty for many.

Stranded migrant labourers and others can collect water bottles, fruits, biscuits, and other eatables free of cost by the people at the stand.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.